Finanzielle Vergleiche Innoviva, Inc.

Aktien

A2AC9U

US45781M1018

INVA

Pharmazeutika

Markt geschlossen - Nasdaq 21:59:21 18.06.2025 % 5 Tage % 1. Jan.
21.46 USD +0.09% Intraday Chart für Innoviva, Inc. -0.33% +23.69%
Hauptkonkurrenten
Umsatz (Y-1) Nettogewinn (Y-1) EBIT-Marge (Y-1) ROE (Y-1) ROA (Y-1) Verschuldungsgrad (Y-1)
359 Mio. - 53.74% - - 0.62x
45.04 Mrd. 23.51%31.78%84.84%14.84%1.88x
88.82 Mrd. 15.84%29.8%34.23%13.95%0.36x
40.31 Mrd. 34.78%44.19%80.78%25.88%0.52x
56.33 Mrd. 7.59%41.43%263.08%13.34%2.56x
66.76 Mrd. 13.68%34.42%43.45%15.69%0.74x
50.32 Mrd. 23.73%38.74%34.74%15.58%0.85x
54.07 Mrd. 13.01%31.31%32.11%12.51%1.47x
64.17 Mrd. 26.68%36.46%46.35%17.38%0.86x
33.42 Mrd. 12.24%44.96%177.29%11.36%2.33x
63.63 Mrd. 12.62%34.24%19.99%8.05%1.52x
28.75 Mrd. 1.67%29.63%27.6%9.57%1.48x
42.53 Mrd. 13.98%27.61%11.75%4.43%0.68x
11.02 Mrd. -4.86%6.31%0.65%0.49%-6.77x
48.3 Mrd. -18.53%10.77%10.23%-9.53%6.49x
7.45 Mrd. 33.09%46.3%22%18.71%-1.74x
39.28 Mrd. 8.21%29.16%48.09%10.97%1.22x
3.83 Mrd. 22.64%26.77%14.73%13.49%-2.98x
28.19 Mrd. 3.38%5.02%2.1%0.36%4.66x
Durchschnitt 40.66 Mrd. 13.51% 31.72% 53% 10.95% 0.88x
Gewichteter Durchschnitt nach Marktkapitalisierung 50.23 Mrd. 16.83% 33.4% 72.26% 13.51% 1.12x
Pharmazeutika - Andere